New Standard of Care in Advanced Renal Cell Carcinoma? New Standard of Care in Advanced Renal Cell Carcinoma?

Combination immunotherapy significantly improved overall survival as compared to standard care with sunitinib as first-line therapy in patients with intermediate- and poor-risk disease.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news